BIOTECH AND PHARMANEWS

‘I’ve Never Viewed Something Care for This’: What We Heard This Week

“I have been doing this for nearly 40 years, and I’ve by no formula seen anything else admire this.” — Wayne L. Furman, MD, of St. Jude Kid’s Be taught Health facility in Memphis, discussing impressive survival charges with an investigational therapy for excessive-threat neuroblastoma in formative years.

“We now must deem out of the sphere to amplify their salvage admission to to care.” — Becky Tilahun, PhD, of the Cleveland Sanatorium, on study suggesting versatile cognitive behavioral therapy over a long timeframe might well furthermore income folk with psychogenic nonepileptic seizures.

“Aspirin is taking a beating, and aspirin might well furthermore still engage a beating.” — Dean Kereiakes, MD, of the Christ Health facility in Cincinnati, discussing trials exhibiting a success suggestions that descend aspirin for certain patients with acute coronary syndrome.

“They wished us to peep this as a rehearsal for the next pandemic. The understanding that became once, let’s faux right here’s a complete recent virus. What will we effect in 100 days?” — Benjamin tenOever, PhD, of NYU Langone Successfully being, on the World Successfully being Group’s name to circulate when Omicron became once discovered.

“The formula I conceptualize plasmapheresis is that Waldenström is admire a home that is on fire.” — Joshua Richter, MD, of the Icahn College of Treatment at Mount Sinai, discussing the must address hyperviscosity, one of many everyday indicators of Waldenström macroglobulinemia, sooner than treating the illness itself.

“The deck is roughly stacked, whilst you are going to, on a complete amount of phases. I make no longer deem or no longer it is fixing one thing. I deem or no longer it is fixing reasonably heaps of a amount of issues.” — Susan Pories, MD, of Mount Auburn Health facility, discussing why feminine physicians are paid much less over the direction of their careers versus their male colleagues.

“Our significant argument with the FDA is that white bagging fundamentally circumvents the [Drug Supply Chain Security Act].” — Kyle Robb, PharmD, of the American Society of Successfully being-Machine Pharmacists, on working to cease the be conscious where a payer mandates that services can finest offer treatment from a narrow choice of payer-affiliated enviornment of expertise pharmacies.

Content Protection by DMCA.com

Back to top button